October 18, 2021

Cold chain facility assures no wastage of Covid jabs

https://www.pna.gov.ph/articles/1152762

Vaccine arrival at the airport (File photo)

MANILA – The Department of Health’s national logistics partner in the government’s Covid-19 vaccination program has assured that no vaccine was wasted since the start of the vaccination rollout early this year.

“As the national logistics partner of the Department of Health (DOH), PharmaServ Express has ensured that no Covid-19 vaccine has been wasted from storage to careful packing and distribution to LGUs since April 2021,” said PharmaServ Express, Inc. President Andrian Perez in a statement.

Perez issued the pronouncement after the DOH reported during its budget hearing at the House of Representatives that the handling of cold-chain facilities for Covid-19 vaccines has remained “very well-managed.”

Health Undersecretary Myrna Cabotaje said that from March to Aug. 20 this year, the DOH recorded 4,528 total wastage in doses, which she described as “very low.” However, she did not mention when or where the wastage occurred.

“From Day One of the country’s vaccine rollout, PharmaServ Express assures the Filipino people that we have always ensured the vaccines we have handled are intact and maintained,” Perez said.

Based on the company’s previous experience working with government agencies and private institutions, Perez said PharmaServ Express “will continue to work hard to provide quality and dependable cold-chain management service to every Filipino family, especially during this Covid-19 pandemic.”

Pharmaserv Express worked with the DOH and the UNICEF in the campaign to stop the measles and polio outbreaks that both occurred in 2019 in various parts of the country.

Due to its timely and efficient delivery of vaccines even to far-flung areas of the Philippines, PharmaServ Express helped end the polio outbreak this year.

PharmaServ Express has also provided the cold-chain and logistical needs of various private pharmaceutical companies in the past years. (PR)

 

Leave a Reply

Your email address will not be published. Required fields are marked *